Studies of a prophylactic HIV-1 vaccine candidate based on modified vaccinia virus Ankara (MVA) with and without DNA priming: Effects of dosage and route on safety and immunogenicity-Reference-Cited by-同舟云学术

Studies of a prophylactic HIV-1 vaccine candidate based on modified vaccinia virus Ankara (MVA) with and without DNA priming: Effects of dosage and route on safety and immunogenicity

Published:2007-03 Issue:11 Volume:25 Page:2120-2127
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Peters Barry S.,Jaoko Walter,Vardas Eftyhia,Panayotakopoulos George,Fast Patricia,Schmidt Claudia,Gilmour Jill,Bogoshi Mampedi,Omosa-Manyonyi Gloria,Dally Len,Klavinskis Linda,Farah Bashir,Tarragona Tony,Bart Pierre-Alexandre,Robinson Andrew,Pieterse Colleen,Stevens Wendy,Thomas Richard,Barin Burc,McMichael Andrew J.,McIntyre James A.,Pantaleo Giuseppe,Hanke Tomáš,Bwayo Job

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference29 articles.

1. Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity;Shiver;Nature,2002

2. Effective induction of simian immunodeficiency virus-specific cytotoxic T lymphocytes in macaques by using a multiepitope gene and DNA prime-modified vaccinia virus Ankara boost vaccination regimen;Hanke;J Virol,1999

3. Induction of AIDS virus-specific CTL activity in fresh, unstimulated peripheral blood lymphocytes from rhesus macaques vaccinated with a DNA prime/modified vaccinia virus Ankara boost regimen;Allen;J Immunol,2000

4. A prime-boost approach to HIV preventive vaccine using a recombinant canarypox virus expressing glycoprotein 160 (MN) followed by a recombinant glycoprotein 160 (MN/LAI). The AGIS Group and l’Agence Nationale de Recherche sur le SIDA;Pialoux;AIDS Res Hum Retroviruses,1995

5. Induction of human immunodeficiency virus type 1 (HIV-1)-specific cytolytic T lymphocyte responses in seronegative adults by a nonreplicating, host-range-restricted canarypox vector (ALVAC) carrying the HIV-1MN env gene;Egan;J Infect Dis,1995

Cited by 94 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genetic-Based Vaccine Vectors;Plotkin's Vaccines;2023

2. Subcutaneous vaccine administration – an outmoded practice;Human Vaccines & Immunotherapeutics;2020-09-29

3. Review of preventative HIV vaccine clinical trials in South Africa;Archives of Virology;2020-08-14

4. A grading system for local skin reactions developed for clinical trials of an intradermal and transcutaneous ETEC vaccine;Vaccine;2020-05

5. Protective HLA alleles are associated with reduced LPS levels in acute HIV infection with implications for immune activation and pathogenesis;PLOS Pathogens;2019-08-26